Navigation Links
Protein Research Marketing Insights
Date:9/23/2008

ARLINGTON, Va., Sept. 23 /PRNewswire/ -- BioInformatics, LLC (http://www.gene2drug.com), the leading market research and consulting firm serving the life science industry, announces the publication of its latest report, "Protein Research: Strategies for Marketing to Chemists and Biologists." A joint effort between BioInformatics, LLC and the American Chemical Society, the report is designed to help suppliers of protein research tools and technologies identify workflow patterns and applications, discover unmet technology needs and explore instrument-purchasing drivers among biologists and chemists.

"A more in-depth understanding of the needs of scientists studying protein research is of growing importance as the field becomes more complex and funding sources become harder to obtain," observed Dr. Tamara Zemlo, Director of Syndicated Research and Analysis for BioInformatics, LLC. "Furthermore, we have identified significant overlap in how biologists and chemists use the equipment, thereby allowing companies to streamline the marketing effort to appeal to scientists in both disciplines."

By exploring the usage and purchase drivers behind both the higher dollar mass spectrometry and HPLC instrumentation, and the less expensive electrophoresis equipment products, manufacturers and scientists alike can understand what, in addition to cost, is influencing purchase decisions. This study explores how these preferences play out differently (and the same) between biologists and chemists.

Designed to help identify key areas of investigation among protein researchers, perceived bottlenecks, potential budgetary implications and customer perceptions of leading providers of instrumentation, this benchmarking study allows suppliers to gain keen insight into the evolving needs of their protein research customers, while more clearly defining certain industry-wide best practices. The information in this report can be used to provide direction as to how suppliers can increase sales volume through innovative product offerings and continue to better meet the needs of current users.

"One of the greatest areas of concern is an ability to meet the higher demand for increased throughput," Zemlo noted. Contained within the report are "Scorecards" for each of the instruments studied. These scorecards provide at-a-glance information as to how biologists and chemists use their protein research tools, what features are most important to them and what kind of purchase criteria they use for choosing vendors.

"Protein Research: Strategies for Marketing to Chemists and Biologists" is based on responses to a 53-question online survey conducted by BioInformatics, LLC. 275 chemists and 443 biologists from North America completed an online survey fielded between June 25 and August 1, 2008. Plan to attend a free webinar to discuss this report on Wednesday, October 22 at 1pm EDT. To register for your virtual seat at the webinar, email m.follin@gene2drug.com. For a complimentary Executive Summary of this report, please visit http://www.gene2drug.com/report/197/

ABOUT BIOINFORMATICS, LLC

BioInformatics, LLC is the premier research and advisory firm serving the life science industry. By leveraging our professional social network of more than 38,000 biomedical researchers, we have supported more than 300 companies and provided insights that lead to better business decisions. Our assignments include assessing the size and attractiveness of markets, optimizing product configurations and pricing, validating corporate acquisitions, measuring customer loyalty, and evaluating brand strength and positioning.

For more information, please contact:

Mary Follin

Director of Communications

BioInformatics, LLC

2111 Wilson Blvd., Suite 250

Arlington, VA 22201

703.778.3080 x13 (phone)

m.follin@gene2drug.com

http://www.gene2drug.com/


'/>"/>
SOURCE BioInformatics, LLC
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Vermillion and Collaborators Discover Protein Biomarker Associated with Peripheral Artery Disease
2. China-Biotics, Inc. Launches Shining Probiotics Protein Powder
3. When proteins, antibodies and other biological molecules kiss, a new kind of biosensor can tell
4. When proteins, antibodies and other biological molecules kiss, a new kind of biosensor can tell
5. New Data Presented on Immunocytokine Fusion Protein Further Supports Broad Anti-Cancer Potential Of Peregrines Anti-PS Technology Platform
6. Baxter Adds Recombinant Protein to Specialty Therapeutics Portfolio
7. Decision Biomarkers Awarded U.S. Patent for Protein Array Surface Chemistry
8. STALLERGENES and Protein eXpert Enter Into a Partnership for Producing Mites Recombinant Allergens
9. Alfacell Announces ONCONASE(R) Purchase and Supply Agreement with Scientific Protein Laboratories
10. Decision Biomarkers Launches System for Faster, Easier Quantification of Protein Biomarkers
11. Immune system protein starves staph bacteria
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... - BIOREM Inc. (TSX-V: BRM) ("Biorem" or "the Company") announces ... Clean Technology Fund I, LP and Clean Technology Fund ... venture capital funds which together hold approximately 59% of ... as converted basis), that they have entered into an ... in Biorem to TUS Holdings Co. Ltd. ("TUS") (en.tusholdings.com) ...
(Date:6/27/2016)... ... 27, 2016 , ... Rolf K. Hoffmann, former senior vice ... University of North Carolina Kenan-Flagler Business School effective June 27. , ... with a focus on the school’s international efforts, leading classes and participating in ...
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial spectrophotometers and ... and the 6000i models are higher end machines that use the more unconventional z-dimension ... light beam from the bottom of the cuvette holder. , FireflySci has developed ...
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT has ... Ontario biotechnology company, Propellon Therapeutics Inc. ... and commercialization of a portfolio of first-in-class WDR5 ... targets such as WDR5 represent an exciting class ... in precision medicine for cancer patients. Substantial advances ...
Breaking Biology Technology:
(Date:4/26/2016)... and LONDON , April 26, ... of EdgeVerve Systems, a product subsidiary of Infosys ... announced a partnership to integrate the Onegini mobile ...      (Logo: http://photos.prnewswire.com/prnh/20151104/283829LOGO ) ... customers enhanced security to access and transact across ...
(Date:4/14/2016)... TEL AVIV, Israel , April 14, 2016 /PRNewswire/ ... in Behavioral Authentication and Malware Detection, today announced the ... has already assumed the new role. Goldwerger,s ... for BioCatch, on the heels of the deployment of ... In addition, BioCatch,s behavioral biometric technology, which discerns unique ...
(Date:3/23/2016)... , March 23, 2016 ... erhöhter Sicherheit Gesichts- und Stimmerkennung mit Passwörtern ... (NASDAQ: MESG ), ein führender ... das Unternehmen mit SpeechPro zusammenarbeitet, um erstmals ... Finanzdienstleistungsbranche, wird die Möglichkeit angeboten, im Rahmen ...
Breaking Biology News(10 mins):